Paratek Pharmaceuticals Strengthens Senior Leadership Team
June 03, 2015 08:00 ET
|
Paratek Pharmaceuticals
Yulii Bogatyrenko joins as Senior Vice President, Business Development
Randall Brenner joins as Senior Vice President, Regulatory Affairs and Quality
BOSTON, June 3, 2015 (GLOBE NEWSWIRE)...
Paratek Pharmaceuticals, Inc. Reports First Quarter 2015 Financial and Operating Results
May 15, 2015 17:36 ET
|
Paratek Pharmaceuticals
Follow-on offering accelerates oral-only indication development and extends funding through top line results of the Phase 3 CABP clinical trial, expected in mid-2017
Initiation of the first...
Paratek Announces Closing of Common Stock Offering
May 05, 2015 16:01 ET
|
Paratek Pharmaceuticals
BOSTON, May 5, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a pharmaceutical company focused on the development and commercialization of innovative, antibacterial therapies...
Paratek Announces Pricing of Public Offering of 2,860,000 Shares of Common Stock
April 29, 2015 23:30 ET
|
Paratek Pharmaceuticals
BOSTON, April 29, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a pharmaceutical company focused on the development and commercialization of innovative, antibacterial therapies...
Paratek Announces Proposed Public Offering of Common Stock
April 27, 2015 16:01 ET
|
Paratek Pharmaceuticals
BOSTON, April 27, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a pharmaceutical company focused on the development and commercialization of innovative, antibacterial therapies...
Paratek Pharmaceuticals, Inc. Reports Full Year 2014 Financial and Operating Results
April 02, 2015 09:26 ET
|
Paratek Pharmaceuticals
BOSTON, April 2, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), today reported financial results for the year ended December 31, 2014.
"We have ended 2014 and our first...
Paratek Pharmaceuticals to Present at Two Upcoming Investor Conferences
March 12, 2015 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, March 12, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a clinical late stage biopharmaceutical company developing and commercializing novel tetracycline based...
Paratek Pharmaceuticals to Present at the Cowen Healthcare Conference
February 23, 2015 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a clinical late stage biopharmaceutical company developing and commercializing novel tetracycline based...
Paratek Pharmaceuticals Adopts Inducement Equity Incentive Plan Under NASDAQ Listing Rule 5635(c)(4)
February 10, 2015 08:39 ET
|
Paratek Pharmaceuticals
BOSTON, Feb. 10, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company, today announced that its Board of Directors has adopted a 2015 Inducement Plan (the...
Paratek Pharmaceuticals to Present at the Leerink Global Healthcare Conference
February 10, 2015 08:00 ET
|
Paratek Pharmaceuticals
BOSTON, Feb. 10, 2015 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a clinical late stage biopharmaceutical company developing and commercializing novel tetracycline based...